Diabetes and COVID-19: Considerations and Clinical Management (Contemporary Endocrinology)
By Alyson K. Myers
Managing COVID-19 alone can be a difficult in many cases, but for persons with pre-existing conditions such as diabetes the challenge can be all the greater, and specific considerations need to be taken when prescribing treatment to manage them. This book is a culmination of scientific work driven by personal conviction to enhance the care provided to the vulnerable populations COVID-19 patients with diabetes. It spans topics from the epidemiology and predictors of complications and increased mortality in COVID-19, to in-depth discussion of the pathophysiology of the disease. Pathophysiology of COVID-19 is addressed comprehensively as common soil pathogenetic pathways, and by organ system such as the lung, the kidney and most pertinently for diabetes, the diabetic foot ulcers and diabetes co-morbidities. A multi-disciplinary approach was needed to manage these complex patients; thus, the authors represent a variety of disciplines including pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine.Written by experts in the field, Diabetes and COVID-19: Considerations and Clinical Management is a blueprint for treatment of patients with both conditions.
Diabetes and COVID-19: Considerations and Clinical Management
By Alyson K. Myers
Managing COVID-19 alone can be challenging, but for individuals with pre-existing conditions such as diabetes, it can be even more difficult. Specific considerations need to be taken into account when prescribing treatment for COVID-19 patients with diabetes. In the book “Diabetes and COVID-19: Considerations and Clinical Management,” author Alyson K. Myers addresses these challenges and provides valuable insights into managing the care of vulnerable populations.
Epidemiology and Predictors of Complications
The book delves into the epidemiology and predictors of complications and increased mortality in COVID-19 patients with diabetes. It explores the pathophysiology of the disease, including common soil pathogenetic pathways and organ-specific effects. With contributions from experts in various disciplines such as pharmacology, endocrinology, nephrology, infectious diseases, podiatry, vascular surgery, pulmonary/critical care, and general medicine, this book offers a comprehensive approach to managing these complex patients.
Enhancing Care for Vulnerable Populations
Alyson K. Myers’s work is driven by a personal conviction to enhance the care provided to vulnerable populations. Her book provides a blueprint for treating patients with both diabetes and COVID-19, equipping healthcare professionals with the necessary knowledge and strategies to optimize patient outcomes. By considering the unique challenges faced by those with diabetes during the COVID-19 pandemic, healthcare providers can offer more targeted and effective care.
Informative and Authoritative
The book, published by Springer, offers a wealth of information and insights. With a total of 237 pages, it covers a wide range of topics related to the management of COVID-19 patients with diabetes. Its authoritative content is based on scientific research and expertise from multiple disciplines. Readers can trust the information provided in the book to be up-to-date and reliable.
Order Your Copy of “Diabetes and COVID-19: Considerations and Clinical Management” Today
Whether you’re a healthcare professional involved in the care of patients with diabetes and COVID-19 or an individual who wants to learn more about managing these conditions, “Diabetes and COVID-19: Considerations and Clinical Management” is an essential resource. By ordering your copy today, you’ll gain access to valuable knowledge and expert insights that can help improve patient outcomes and enhance your understanding of these complex medical challenges.
Video Promotion
Watch this video to learn more about the book and how it can benefit healthcare professionals:
Get Your Copy Now
Don’t miss out on the opportunity to enhance your knowledge and expertise in managing COVID-19 patients with diabetes. Order your copy of “Diabetes and COVID-19: Considerations and Clinical Management” today and stay at the forefront of medical advancements in these challenging times.
- Publisher: Springer; 1st ed. 2023 edition (June 11, 2023)
- Language: English
- Format: eBook Digital
- Pages: 237
- ISBN-10: 3031285352
- ISBN-13: 978-3031285356
Product Details
- Publisher : Springer; 1st ed. 2023 edition (June 11, 2023)
- Language : English
- Hardcover : 237 pages
- ISBN-10 : 3031285352
- ISBN-13 : 978-3031285356